Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

42.57
Delayed Data
As of 4:02pm ET
 -0.38 / -0.88%
Today’s Change
37.20
Today|||52-Week Range
45.58
+10.54%
Year-to-Date

Today’s Trading

Previous close42.95
Today’s open42.58
Day’s range42.38 - 42.72
Volume4,635,934
Average volume (3 months)3,176,205
Market cap$105.6B
Dividend yield4.67%
Data as of 4:02pm ET, 05/25/2017

Growth & Valuation

Earnings growth (last year)-90.48%
Earnings growth (this year)+12.50%
Earnings growth (next 5 years)+5.90%
Revenue growth (last year)+2.85%
P/E ratio62.4
Price/Sales2.52
Price/Book75.28

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie+0.39+0.59%
CELGCelgene-1.01-0.86%
BMYBristol-Myers Squibb+0.57+1.06%
LLYEli Lilly and Co+0.38+0.49%
Data as of 4:01pm ET, 05/25/2017

Financials

Next reporting dateJuly 26, 2017
EPS forecast (this quarter)$0.69
Annual revenue (last year)$37.5B
Annual profit (last year)$1.2B
Net profit margin3.27%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Emma Walmsley
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts